Skip to main content
. 2012 Jan 19;27(4):947–953. doi: 10.3892/or.2012.1649

Table II.

Univariate and multivariate analysis of prognostic factors for OS and DFS in Dukes' stage B patients.

Univariate analysis Multivariate analysis


Variables Regression coefficient Hazard ratio (95% CI) P-value Regression coefficient Hazard ratio (95% CI) P-value
OS
Tumor size 0.349 1.417 (0.521–3.858) 0.488 (−)
Lymphatic invasion 0.674 1.962 (0.665–5.303) 0.209 (−)
Venous invasion 1.109 3.030 (1.054–10.846) 0.039a 1.017 2.765 (0.961–9.905) 0.060
Histological type −0.235 0.791 (0.181–2.455) 0.708 (−)
Serum CEA 0.744 2.105 (0.768–5.777) 0.145 (−)
Serum CA19-9 0.588 1.800 (0.394–6.235) 0.409 (−)
CEA/CK/CD133 2.347 10.456 (2.119–189.993) 0.001a 2.284 9.819 (1.987–177.568) 0.002a
DFS
Tumor size 0.053 1.055 (0.479–2.286) 0.892 (−)
Lymphatic invasion 0.570 1.768 (0.775–3.844) 0.169 (−)
Venous invasion 0.840 2.316 (1.040–5.645) 0.040a 0.619 1.857 (0.824–4.569) 0.139
Histological type 0.376 1.456 (0.597–3.242) 0.389 (−)
Serum CEA 0.798 2.222 (0.823–4.901) 0.064 (−)
Serum CA19-9 0.240 1.271 (0.360–3.546) 0.680 (−)
CEA/CK/CD133 1.150 3.158 (1.286–9.462) 0.011a 1.282 3.602 (1.454–10.863) 0.005a
a

P<0.05.